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The epithelial-mesenchymal transition (EMT) has been found by us a n d o t h e r s to induce normal and neoplastic mammary epithelial cells (MECs) to acquire mesenchymal traits and, in addition, many of the characteristics of stem cells. However, none of these observations showed that the products of EMT are actually bona fide stem cells. To demonstrate this, I had optimized efficient EMT induction in several different cell types, tested new ways of separating stem cell and non-stem cell populations of normal and breast cancer cells and identified EMT transcription factors most likely involved in stem cell biology. Preliminary results directly demonstrate that transient induction of EMT increases the number of mammary epithelial stem cells capable of generating an entire mammary ductal tree. With these observations and optimizations I can now move closer to uncovering the connection between EMT and entrance into a stem-cell state. The outcome of these experiments holds important implications for the mechanisms controlling the formation of normal mammary epithelial stem cells as well as the formation of breast cancer stem cells.
SUBJECT TERMS
Epithelial-Mesenchymal Transition, Cancer Stem Cell, Normal Stem Cell
INTRODUCTION
Metastatic invasion, the most feared feature of cancer, requires neoplastic epithelial cells to loose cell-cell attachment and to gain motility. The molecular process known to be responsible for this malignant change is called epithelial-mesenchymal transition (EMT). Recently, our lab oratory and others un covered an unanticipated, indirect link between the EMT and stem cells Morel et al., 2008) . Ste m cells have the unique ability to self -renew almost infinitely and to give rise to all cell types in the body. Tumor tissues also contain such se lf-renewing, stem-like cells, which are called cancer stem cells (CSCs) and which carry the source of a tumor's ability to grow and regenera te. It was sh own that th e cells that underwent EMT acquired som e of the properties of stem cells; mainly the expres sion of stem cell surface markers and an increased ability to form mammospheres. My proje ct aims to identif y whether EMT is involved in in vivo formation and maintenance of normal and cancer stem cells. The first part of m y study focuses on the role of EMT in t he formation of normal stem cells. I am testing whether induction of an EMT in m urine mammary epithelial cells (MECs) is able to convert them into bona fide stem cells capable of forming the entire mammary gland in vivo. The first year of m y research involved the optimization of in vitro culture conditions for prim ary murine epithelial cells, im proving the lentiviral transduction efficiency of these cells and examining the suitability of individual EMT transcription factors for induction of EMT in prim ary murine epithelial cells. In addition, I ha ve also perform ed a preliminary study of the effect of EMTed cells on mammary gland reconstitution.
In the next part of m y project I am examining the role of EMT in the form ation of breast cancer stem cells and studying whether EMT-inducing transcription factors also play a role in the maintenance of CSCs within tumors. The first year of m y research was directed towards cloning of inducible hum an versions of EMTtranscription factors, optimization of conditions for efficient EMT induction and preliminary examination of tumor-initiating abilities of EMTed cells in xenograft breast tumor model.
Solving and setting up these condi tions allows me to move closer towards elucidating the role of EMT in normal and cancer stem cell proces ses. Better understanding of mammary stem cell biology will ultim ately lead us to a better understanding of br east cancer stem cells, which is cruc ial for the future developm ent of anti-cancer therapies. By finding an easy way to generate large numbers of cancer stem cells at will, we will gain the opportunity to study these in great detail, to uncover their m aintenance mechanisms, and to screen for therapeutic agents to specifically eliminate them. This would be a highly effe ctive approach to finding cures, since it would strike right at the "heart" o f a tumor, halting the eventual regrowth of the tum or mass and thus preventing clinical relapses.
BODY

The Role of EMT in the Formation of Mammary Epithelial Stem Cells
I am investigating whether inductio n of an EMT in prim ary mouse MECs can significantly and efficiently increase their mammary gland-reconstituting activity, thereby converting them into bona fide stem cells. For this purpose, murine mammary epithelial cells have to be isolated from mouse mammary gland, incubated in vitro and transduced with lentiviral vectors carrying doxycycline inducible EMT-transcription factors (EMTTFs). These cells will then be induced to undergo EMT and will be in jected into cleared mammary fat pads, followed by the examination of their gland-reconstituting activity.
These steps involve a number of technical obstacles. One of the hurdles is the known difficulty to transduce primary murine epithelial cells efficiently. Even though I am planning to use powerful lentiviral systems for the delivery of EMT-TFs into the ce lls, it has been m y experience and that of others that one round of infection will give around 8% of tr ansduction efficiency. By concentra ting the virus the efficiency m ight increase to 30%. My experim ents require better delivery efficiency and since prim ary MECs are very sensitive to cell sorting techniques, it is difficult to separate the transduced population. Also, primary murine epithelial cells grow in culture only up to 12-15 da ys before undergoing senescen ce and/or cell death. This limitation prevents me from using drug selection as one of the possibilities to elim inate cells that were not transduced. Therefore, I attempted to optimize the conditions of infection of prim ary mouse MECs by lentivirus vectors. Indeed, by optimizing transfection and transduction protocols I developed conditions that now allow ~90% infection efficiency, which is m ore than 10-fold greater infection rate than was previously possible (Figure 1 ). Next, I had to establish which of the m any EMT-transcription factors is most suitable for my experiments; seeking the EMT factor that is ca pable of inducing potent EMT and that is specifically associated w ith mammary gland stem cells. Even though Twist was show n to be a powerful EMT inducer in hum an cells these effects are tissue and species-specific and m ight not be the sam e in the context of murine cells. Therefore, I separated, by cell sorting, three distin ct subpopulations of murine MECs pr epared from mammary glands of ~3 month-old m ice using cell-surface antigenic markers developed by others (AsselinLabat et al., 2007; Stingl et al., 2006) . More specifically, the stem cell-enriched CD49f high /CD61 + basal population was separated from CD49f low CD61
+ luminal progenitor cells and from CD49f low CD61 -fully differentiated luminal cells (Figure 2 ). I then used quantitative RT-PCR to examine the expression profile of eight major EMT-TFs in these subpopulations. As co mpared to the differentiated m ammary MECs, the normal mammary gland stem cells e xpressed high levels of Slug (~90x) and Sna il (~15x) and a m ildly elevated levels of Twist (~4x) (Figu re 2). This persuaded m e that Slug, Snail and/or Twist were likely to have some function in the mammary stem cell state. Consistent with previous reports (Lim et al., 2010; Mani et al., 2008) , the cells in stem cell-enriched basal population also expr essed relatively high levels of mesenchymal markers, such as N-cadherin, vim entin, and low levels of epithelial m arkers, specifically Ecadherin (Figure 2 ). The analysis of published m icroarray data of various hum an mammary epithelial cell subpopulations confirmed that S lug is also the EMT-TF that is m ost highly expressed by hum an stem cellenriched cell population (Lim et al., 2010) . (Figure 3 ). This change was more rapid in cells over-expressing Slug (5 days) than in cells over-expressing Snail (12 days). Slug and Snail also induced higher expression of mesenchymal markers in prim ary MECs (Figure 3) . Surprisingly, even though cells over-expressing Snail and Slug manifested almost com plete mesenchymal morphology, the protein levels of E-cadherin were not decreased. Similar observation was noted by others in human MCF7 cell line. W hen this cell line wa s manipulated to undergo EMT its E-cadhe rin protein levels remained the same, instead it was the E-cadherin subcellular localization that had ch anged from a membrane to a cytoso lic position (Micalizzi et al., 2009) . Immunofluorescence analysis will need to be perform ed to clarify these issues in the context of pri mary murine epithelial cells. Expression of Twist had very toxic effect on pr imary murine epithelial cells and I have, therefore, excluded it from further analysis (Figure 3 ). Next, I have used the in vivo cleared mammary fat pad reconstituti on assay to m easure whether Slug-and Snail-induced EMTed prim ary murine cells contain m ore mammary stem cells than the non-E MTed cells. This mouse in vivo regeneration assay was developed by Smith a nd Medina (1988) , and is aimed at isolation and characterization of mammary epithelial stem cells. In this assay, 3-week old m ice have the portion of their stromal compartment of the m ammary gland (called mammary fat pad), containing the m ammary epithelial tree, cleared away. Cells of interest are injected into such cleared fat pads and if the injected cells contain mammary epithelial stem cells, an entire m ammary ductal tree can be regenerated. Otherwise, the cleared fat pad remains devoid of mammary epithelium . The preliminary test I have perform ed involved the implantation of EMTed and non-EMTed cells into clear ed mouse mammary stromal fat pads, with the hope that the proportion of mammary gland-generating stem cells would be greatly increased by prior exposure of cells to an EMT-inducing transcription factors. This experiment was done in collaboration with my colleague Dr. Wenjun Guo, who is studying the m aster regulators of mammary gla nd morphogenesis and who has an extensive knowledge of the fat pad reconstitution essay. As mentioned earlier, primary murine epithelial cells gr ow in cu lture only up to 12-15 days before undergoing senescence and/or cell d eath. Experimenting with different in vitro culturing media, as well as growing these cells under a hypoxic (~3% oxygen) conditi ons that m ore closely correspond to intravital physiologic conditions, did not ex tend their life span (d ata not shown). This limitation prevented me from inducing full EMT in vitro. W e were, therefore, induc ing Snail, Slug and Lucife rase cells with doxycycline for 5 days in vitro, followed by inje ction of these cells into female NOD/SCID mice (2-3 mice per group) at limiting dilutions (2000 cells and 400 cells) and continued inducing the f actors for one m ore week in vivo. We then analyzed the mammary glands 8 weeks after implantation. The ability of EMTed cells to regenerate mammary ductal tree s was increa sed several fold when compared with contro l cells (Fig ure 4) . This preliminary experiment will require reproduction on a larger number of mice. It is possible th at, in order to increase the efficiency of the conversion of EMTed cells into stem cells, I will need to over-express a combination of EMT-inducing transc ription factors or that EMT fact ors might need a cofactor. These experiments and optimizations are currently underway. 
The Role of EMT in the Formation of Breast Cancer Stem Cell
In this part of the project I am studying the role of EMT in the for mation of breast cancer stem cells and examining whether EMT-inducing transc ription factors also play a role in the maintenance of CSCs within tumors. To begin with, I wanted to induce EMT in human breast cancer MCF7ras cells through inducible-EMT transcription factors in vitro, followed by injection of these EMTed cells into fat pads and later analysis of resulting tumor formation. I wanted to test whet her the tum or initiating ability, one of the m ajor characteristics of CSC, of EMTed cells increases as compared to non-EMTed cells.
Since my previous studies and those of my colleagues have shown the leakiness of the tamoxifen inducible system (there was a sig nificant expression of the cl oned genes even in the absence of tam oxifen) I have decided to use doxycycline system instead. Human versions of various EMT transcription factors (Snail, Twist1, Slug, Zeb1) and control molecules (Luciferase, BclXL) were cloned into doxycycline Tet-ON vector with or without IRES-GFP sequence (F igure 5). I have chosen to use the IRES-GFP sequence for easier control of the expressi on status of cloned EMT fact ors. One of the explanations of getting a higher tum orinitiating ability with EMTed cells might be the anti-apoptotic effect of EMT transcription factors (Maestro et al., 1999; Cheng et al., 2007; Onder et al., 2008) . Th erefore, I have included anti-apoptotic molecule BclXL as a contro l. As an initia l cell line I have chosen hum an breast cancer MCF7ras c ells which is an epithelial, non-metastatic, widely characterized cell line. I have transduced MCF7ras cell line with the cloned vectors and induced the expression of EMT factors and control factors with doxycycline for 5 days in vitro.
Their efficient, non-leaky expressi on was confirmed by fluorescent m icroscopy, Western Blot and RT-PCR ( Figure 5 ). However, I was unable to induce EMT with these factors in vitro as gauged by absent m esenchymal morphology phenotype and negative W estern Blot for cha nges in the levels of epithelial and m esenchymal markers (data not shown). I tested higher doses (up to 10 µg/ml) and longer exposures of doxyc ycline (up to 28 days), plating cells on collagen (to test whether more suitable matrix will help), detaching cells from plate through adding trypsin (hoping that te mporary break-down of cell-cell a dhesions might help induce EMT), and combination of EMT transcription factors w ithout success. Next, I wa nted to tes t whether in vivo environment coupled with the expression of EM T factors might be more appropriate to induce EMT. Som e authors have reported that in vivo environment might help to induce EMT in breast cancer cells (Santisteban et al 2009) . Mesenchymal stem cells were also shown to increase the in vivo growth kinetics and metastatic potential of MCF7ras cells (Karnoub et al 2007) and it m ight be possible that this effect occurs through the induction of EMT in vivo. Therefore, I injected MCF7ras cells which were transduced with EMT factors and control factors into NOD-SCID m ice at 10 5 cells/fat pad. I induced EM T-factors and GFP control cells with doxycycline for 14 days in vivo (through the doxycycline-containing water) . Cells were then extracted from mice, separated by cell sorting using GFP as a m arker and analyzed by RT-PCR for the expression of epithelial and m esenchymal markers (Figure 7) . The RT-PCR results ha d shown EMT induction in Snail, Slug and Zeb-1 over-expressing MCF7 ras cells as opposed to GFP cont rol (I didn't retrieve enough Twistcontaining cells from mice to perform RT-PCR). I could not include all the known EMT-factors in my study so I have chosen to work with Snail, Twist1 and Zeb1 since they rep resent members of different EMT-transcription factor families and they have been extensively characterized in our la b. However, the f ailure of these th ree factors to incr ease the tum orinitiating properties of EMT-ed cells m ade me wonder whether I have used the appropriate EMT -transcription factors. While it is relatively easy to find out which EMT-factors are over-expressed in the stem cell portion of som e breast cancer cell lines (thr ough known CD24/44 m arkers) it is not easy in MCF7ras cells where CD24/44 markers does not seem to work (Figure 9 ). In order to separate the stem-cell enriched MCF7ras population I have used the m ethod described in the Pece et al, 2010 , where the stem cells are separated on the basis of their ability to retain the lipophilic dye PKH26 as a conseque nce of their quiescent nature. I labeled MCF7ras cells with red fluorescent dye and plated them in the mammosphere media. After 12-15 days of m ammosphere culture m ajority of cells within the f ormed mammospheres lost red fluorescence and only small percentage of cells had retained it. These cells were separated by cell sorting and their EMT-expression profiles and mammosphere forming ability were analyzed as opposed to the cells that did not re tain the dy e (Figure 9 ). Mammosphere f orming-ability of label-retaining cells was 8 f old higher than that of non-retaining cells confirming that the label-retaining cells are enriched for stem cells. RT-PCR profile showed that Slug is greatl y over-expressed (over 600 fold) in th e stem cell-enriched population of MCF7ras cells (Figure 9 ). Therefore, I have decided to start using Sl ug in m y future exp eriments with MCF7ras cells and the tum or-initiating studies usi ng Slug are currently underw ay. This presented an interesting convergence with the first part of m y project where I have also characterized Slug as being the EMT-factor most likely to be involved in mammary stem cell biology. Even though MCF7ras cell line was the in itial cell line for m y studies, sim ilar experiments are being performed by m e using HMLE cell line. This w ill allow me to exam ine whether EMT has a r ole in the formation of cancer stem cells in a variety of cancer cell lines. HMLE system is well characterized by our lab and is known to undergo a robust EMT whe n given appr opriate signals. In order to m ake HMLE cells tumorigenic I over-expressed wild type HER2 molecule in these ce lls to a leve l comparable to natura lly occurring HER2-positive breast cancer cell line BT474 (Figure 10 (Figure 10 ). These measurements revealed that while Snail and Twist are over-expressed 5-6 fold relative to non-stem cells, Zeb1 EMT-inducing transcription factor is over-expressed by a factor of ~50 relative to nonstem cells. The contrib ution of these EMT factors to the stem cell state of HMLE-HER2 cells is now bein g investigated in vivo.
and identified EMT transcription factors most likely involved in stem cell biology. Major, albeit preliminary, results directly demonstrated that transient induction of EMT increases the num ber of ma mmary epithelial stem cells capable of generating an entire mammary ductal tree. With these observations and optimizations I can now move closer t o uncovering the connection between EMT and entran ce into a stem-cell state. The outcome of t hese experiments holds im portant implications for the mechanisms controlling the for mation of normal mammary epithelial stem cells as well as the formation of breast cancer stem cells.
